Sandu Pharmaceuticals share news, announcements and annual reports
BSE: 524703Pharmaceuticals & BiotechnologySmall Cap
Sandu Pharmaceuticals Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹35.31down ₹1.52 (4.13%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹36.83.
29 Oct: open ₹37.06, high ₹37.06, low ₹35.31
52-week range of traded prices to 29 Oct 2026
₹30.00Low, 30 Mar 2026₹50.00High, 27 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹34 Cr3,677th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.26
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,358
Sandu Pharmaceuticals board meetings
142 filed, newest first. Page 3 of 3.
Jul 2020
27 Jul · Board meeting
Meeting on 31 Jul 2020: audited results
Jun 2020
25 Jun · Board meeting
Feb 2020
14 Feb · Board meeting
Jan 2020
15 Jan · Board meeting
Meeting on 14 Feb 2020: quarterly results
Nov 2019
14 Nov · Board meeting
Oct 2019
30 Oct · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
13 Aug · Board meeting
Jul 2019
26 Jul · Board meeting
Meeting on 13 Aug 2019: quarterly results
May 2019
29 May · Board meeting
16 May · Board meeting
Meeting on 29 May 2019: audited results
Mar 2019
25 Mar · Board meeting
13 Mar · Board meeting
Meeting on 25 Mar 2019
Feb 2019
Jan 2019
25 Jan · Board meeting
Meeting on 14 Feb 2019: quarterly results
Nov 2018
Oct 2018
Oct 2017
23 Oct · Board meeting
Aug 2017
Mar 2017
Feb 2017
Jan 2017
Nov 2016
14 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2016, inter alia, has discussed the following business: - ....
Sep 2016
Aug 2016
13 Aug · Board meeting
Meeting of the Board of Directors of the Company duly convened on August 13, 2016, inter alia, discussed the following business - 1. ....
Feb 2016
13 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 13, 2016, inter alia, has transacted following business: 1. ....
Nov 2015
15 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2015, inter alia, has discussed the following business: - ....
Sep 2015
30 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 30, 2015, inter alia, has transacted the following: 1. To appoint ....
Aug 2015
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 13, 2015, inter alia, has discussed the following business : 1. ....
May 2015
Mar 2015
30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 30, 2015, has appointed Dr. Mrs. Shubhada P. Sandu as the Woman Director ....30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 30, 2015, and in accordance with the provisions of Section 203 of Companies ....5 Mar · Board meeting
Shri Nikesh Shah has been appointed as the Chief Financial Officer (CFO) of the Company with effect from March 02, 2015 in accordance with ....
Aug 2011